Literature DB >> 21937853

Structures, biosynthesis, and functions of gangliosides--an overview.

Robert K Yu1, Yi-Tzang Tsai, Toshio Ariga, Makoto Yanagisawa.   

Abstract

Gangliosides are sialic acid-containing glycosphingolipids that are most abundant in the nervous system. Heterogeneity and diversity of the structures in their carbohydrate chains are characteristic hallmarks of these lipids; so far, 188 gangliosides with different carbohydrate structures have been identified in vertebrates. The molecular structural complexity increases manifold if one considers heterogeneity in the lipophilic components. The expression levels and patterns of brain gangliosides are known to change drastically during development. In cells, gangliosides are primarily, but not exclusively, localized in the outer leaflets of plasma membranes and are integral components of cell surface microdomains with sphingomyelin and cholesterol from which they participate in cell-cell recognition, adhesion, and signal transduction. In this brief review, we discuss the structures, metabolism and functions of gangliosides.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937853      PMCID: PMC3684167          DOI: 10.5650/jos.60.537

Source DB:  PubMed          Journal:  J Oleo Sci        ISSN: 1345-8957            Impact factor:   1.601


  51 in total

Review 1.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

2.  A trisialoganglioside containing a sialyl alpha 2-6 N-acetylgalactosamine residue is a cholinergic-specific antigen, Chol-1 alpha.

Authors:  S Ando; Y Hirabayashi; K Kon; F Inagaki; S Tate; V P Whittaker
Journal:  J Biochem       Date:  1992-03       Impact factor: 3.387

3.  A novel ganglioside in dogfish brain. Occurrence of a trisialoganglioside with a sialic acid linked to N-acetylgalactosamine.

Authors:  K Nakamura; F Inagaki; Y Tamai
Journal:  J Biol Chem       Date:  1988-07-15       Impact factor: 5.157

4.  b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve.

Authors:  Masahiko Okada; Michi-ichiro Itoh Mi; Masashi Haraguchi; Tetsuya Okajima; Masahiro Inoue; Hideto Oishi; Yoichi Matsuda; Tsutomu Iwamoto; Toshihiro Kawano; Satoshi Fukumoto; Hiroshi Miyazaki; Keiko Furukawa; Shinichi Aizawa; Koichi Furukawa
Journal:  J Biol Chem       Date:  2001-10-26       Impact factor: 5.157

5.  Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.

Authors:  Michael A Simpson; Harold Cross; Christos Proukakis; David A Priestman; David C A Neville; Gabriele Reinkensmeier; Heng Wang; Max Wiznitzer; Kay Gurtz; Argyro Verganelaki; Anna Pryde; Michael A Patton; Raymond A Dwek; Terry D Butters; Frances M Platt; Andrew H Crosby
Journal:  Nat Genet       Date:  2004-10-24       Impact factor: 38.330

6.  A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice.

Authors:  S Chiavegatto; J Sun; R J Nelson; R L Schnaar
Journal:  Exp Neurol       Date:  2000-12       Impact factor: 5.330

7.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

8.  Developmental changes in ganglioside composition and synthesis in embryonic rat brain.

Authors:  R K Yu; L J Macala; T Taki; H M Weinfield; F S Yu
Journal:  J Neurochem       Date:  1988-06       Impact factor: 5.372

9.  Alzheimer disease - effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme.

Authors:  Lars Svennerholm; Görel Bråne; Ingvar Karlsson; Annika Lekman; Ingalill Ramström; Carsten Wikkelsö
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

10.  Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells.

Authors:  R Kannagi; N A Cochran; F Ishigami; S Hakomori; P W Andrews; B B Knowles; D Solter
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  120 in total

1.  Single cell ganglioside catabolism in primary cerebellar neurons and glia.

Authors:  David C Essaka; Jillian Prendergast; Richard B Keithley; Ole Hindsgaul; Monica M Palcic; Ronald L Schnaar; Norman J Dovichi
Journal:  Neurochem Res       Date:  2012-03-11       Impact factor: 3.996

2.  Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8.

Authors:  Qi Zhao; Mahiuddin Ahmed; Hong-fen Guo; Irene Y Cheung; Nai-Kong V Cheung
Journal:  J Biol Chem       Date:  2015-04-07       Impact factor: 5.157

3.  Enhanced expression of unique gangliosides with GM2-determinant in human uterine cervical carcinoma-derived cell lines.

Authors:  Kyoko Tanaka; Masaki Miyazawa; Mikio Mikami; Daisuke Aoki; Kazushige Kiguchi; Masao Iwamori
Journal:  Glycoconj J       Date:  2016-06-06       Impact factor: 2.916

4.  Histochemical and immunoelectron microscopic analysis of ganglioside GM3 in human kidney.

Authors:  Tetsuya Kaneko; Yoshiharu Tsubakihara; Hiroaki Fushimi; Seiji Yamaguchi; Yoshitsugu Takabatake; Hiromi Rakugi; Hayato Kawakami; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2014-07-02       Impact factor: 2.801

Review 5.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

Review 6.  Epigenetic regulation of ganglioside expression in neural stem cells and neuronal cells.

Authors:  Yutaka Itokazu; Yi-Tzang Tsai; Robert K Yu
Journal:  Glycoconj J       Date:  2016-08-19       Impact factor: 2.916

7.  Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice.

Authors:  Denggao Yao; Rhona McGonigal; Jennifer A Barrie; Joanna Cappell; Madeleine E Cunningham; Gavin R Meehan; Simon N Fewou; Julia M Edgar; Edward Rowan; Yuhsuke Ohmi; Keiko Furukawa; Koichi Furukawa; Peter J Brophy; Hugh J Willison
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

8.  Gangliosides Destabilize Lipid Phase Separation in Multicomponent Membranes.

Authors:  Yang Liu; Jonathan Barnoud; Siewert J Marrink
Journal:  Biophys J       Date:  2019-09-06       Impact factor: 4.033

9.  Expression of tyrosine kinase receptors in cultured dorsal root ganglion neurons in the presence of monosialoganglioside and skeletal muscle cells.

Authors:  Hao Li; Weiwei Zhang; Guixiang Liu; Jianmin Li; Huaxiang Liu; Zhenzhong Li
Journal:  J Muscle Res Cell Motil       Date:  2012-09-12       Impact factor: 2.698

10.  Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro.

Authors:  Jing Wang; Robert K Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.